+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Molecular Biomarker"

From
Biomarkers Global Market Report 2024 - Product Thumbnail Image

Biomarkers Global Market Report 2024

  • Report
  • December 2023
  • 200 Pages
  • Global
From
From
From
From
Biomarkers: Technologies and Global Markets 2021 - Product Thumbnail Image

Biomarkers: Technologies and Global Markets 2021

  • Report
  • March 2021
  • 216 Pages
  • Global
From
From
From
From
Biomarkers - Technologies, Markets & Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets & Companies

  • Report
  • November 2021
  • 1032 Pages
  • Global
From
Loading Indicator

Molecular biomarkers are molecules that can be used to identify and measure biological processes, such as disease states or drug responses. They are used in a variety of applications, including diagnostics, drug development, and personalized medicine. Molecular biomarkers are typically proteins, nucleic acids, or metabolites that can be measured in a variety of biological samples, such as blood, urine, or tissue. The molecular biomarker market is a rapidly growing segment of the larger biomarker market. It is driven by advances in technology, such as next-generation sequencing and mass spectrometry, which have enabled the identification and quantification of molecular biomarkers with greater accuracy and sensitivity. Additionally, the increasing prevalence of chronic diseases and the need for personalized medicine are driving the demand for molecular biomarkers. Some companies in the molecular biomarker market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Bio-Rad Laboratories. Show Less Read more